소 혈장 유도체 시장 제품, 유도체 유형, 소스 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)

Bovine Blood Plasma Derivatives Market - Scope of Report

TMR's report on the global bovine blood plasma derivatives market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global bovine blood plasma derivatives market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global bovine blood plasma derivatives market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the bovine blood plasma derivatives market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global bovine blood plasma derivatives market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global bovine blood plasma derivatives market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global bovine blood plasma derivatives market.

The report delves into the competitive landscape of the global bovine blood plasma derivatives market. Key players operating in the global bovine blood plasma derivatives market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global bovine blood plasma derivatives market profiled in this report.

Key Questions Answered in Global bovine blood plasma derivatives Market Report:

• What is the sales/revenue generated by bovine blood plasma derivatives across all regions during the forecast period?
• What are the opportunities in the global bovine blood plasma derivatives market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Bovine Blood Plasma Derivatives Market - Research Objectives and Research Approach

The comprehensive report on the global bovine blood plasma derivatives market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global bovine blood plasma derivatives market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global bovine blood plasma derivatives market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Bovine Blood Plasma Derivatives Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Product Definition
  • 4.1.2. Industry Evolution / Developments
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, 2020-2034
  • 4.4.1. Market Revenue Projections (US$ Bn)
  • 4.4.2. Market Volume/Unit Shipments Projections
• 4.5. Porter's Five Forces Analysis

5. Key Insights

• 5.1. Value Chain Analysis
  • 5.1.1. Prominent Companies in Bovine Blood Plasma Derivatives Value Chain
  • 5.1.2. List of Key End-user
• 5.2. Porters Five Forces of Analysis
• 5.3. Price trend of raw material bovine plasma from 2010-2030
• 5.4. Global Bovine Blood Plasma Derivatives: Demand and Supply Scenario
• 5.5. Regulatory Scenarios
• 5.6. Key Industry Events
• 5.7. Technology Overview
  • 5.7.1. Overview of Bovine Blood Plasma Derivatives Process
    • 5.7.1.1. Bovine Serum Albumin (BSA)
    • 5.7.1.2. Immunoglobulin
    • 5.7.1.3. Fetal Bovine Serum (FBS)
    • 5.7.1.4. Technology -Summary of blood collection and processing methods
  • 5.7.2. Overview of Bovine Blood Plasma Yield
• 5.8. Distributors Landscape
• 5.9. Major Brand Analysis
• 5.10. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

6. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Product

• 6.1. Introduction & Definition
• 6.2. Key Findings/Developments
• 6.3. Market Value Forecast, by Product, 2020-2034
  • 6.3.1. Kits and Reagents
  • 6.3.2. Instruments
  • 6.3.3. Software and Service
• 6.4. Market Attractiveness Analysis, by Product

7. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Technology

• 7.1. Introduction & Definition
• 7.2. Key Findings/Developments
• 7.3. Market Value Forecast, by Technology, 2020-2034
  • 7.3.1. Molecular Diagnostics
  • 7.3.2. Hematology
  • 7.3.3. Immunodiagnostics
  • 7.3.4. Others
• 7.4. Market Attractiveness Analysis, by Technology

8. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Derivative Type

• 8.1. Introduction & Definition
• 8.2. Key Findings/Developments
• 8.3. Market Value Forecast, by Derivative Type, 2020-2034
  • 8.3.1. Immunoglobulin
  • 8.3.2. Fibrinogen
  • 8.3.3. Serum Albumin
  • 8.3.4. Fetal Bovine Serum
  • 8.3.5. Thrombin
  • 8.3.6. Transferrin
  • 8.3.7. Others
• 8.4. Market Attractiveness Analysis, by Derivative Type

9. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Source

• 9.1. Introduction & Definition
• 9.2. Key Findings/Developments
• 9.3. Market Value Forecast, by Source, 2020-2034
  • 9.3.1. US Grade
  • 9.3.2. Australia Grade
  • 9.3.3. New Zealand Grade
  • 9.3.4. Others
• 9.4. Market Attractiveness Analysis, by Source

10. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by End-user

• 10.1. Introduction & Definition
• 10.2. Key Findings/Developments
• 10.3. Market Value Forecast, by End-user, 2020-2034
  • 10.3.1. Veterinary Industry
    • 10.3.1.1. Veterinary Hospitals
    • 10.3.1.2. Veterinary Reference Laboratories
    • 10.3.1.3. POC/In House Testing
    • 10.3.1.4. Veterinary Research laboratories
  • 10.3.2. Food Industry
  • 10.3.3. Academic and Research Institutes
  • 10.3.4. Cell Culture/ Biotechnology
  • 10.3.5. Cosmetic Industry
  • 10.3.6. Pharmaceutical Industry
  • 10.3.7. Diagnostics Industry
  • 10.3.8. Others
• 10.4. Market Attractiveness Analysis, by End-user

11. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Region

• 11.1. Key Findings
• 11.2. Market Value Forecast, by Region, 2020-2034
  • 11.2.1. North America
  • 11.2.2. Europe
  • 11.2.3. Asia Pacific
  • 11.2.4. Latin America
  • 11.2.5. Middle East & Africa
• 11.3. Market Attractiveness Analysis, by Region

12. North America Bovine Blood Plasma Derivatives Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Product, 2020-2034
  • 12.2.1. Kits and Reagents
  • 12.2.2. Instruments
  • 12.2.3. Software and Service
• 12.3. Market Value Forecast, by Technology, 2020-2034
  • 12.3.1. Molecular Diagnostics
  • 12.3.2. Hematology
  • 12.3.3. Immunodiagnostics
  • 12.3.4. Others
• 12.4. Market Value Forecast, by Derivative Type, 2020-2034
  • 12.4.1. Immunoglobulin
  • 12.4.2. Fibrinogen
  • 12.4.3. Serum Albumin
  • 12.4.4. Fetal Bovine Serum
  • 12.4.5. Thrombin
  • 12.4.6. Transferrin
  • 12.4.7. Others
• 12.5. Market Value Forecast, by Source, 2020-2034
  • 12.5.1. US Grade
  • 12.5.2. Australia Grade
  • 12.5.3. New Zealand Grade
  • 12.5.4. Others
• 12.6. Market Value Forecast, by End-user, 2020-2034
  • 12.6.1. Veterinary Industry
    • 12.6.1.1. Veterinary Hospitals
    • 12.6.1.2. Veterinary Reference Laboratories
    • 12.6.1.3. POC/In House Testing
    • 12.6.1.4. Veterinary Research laboratories
  • 12.6.2. Food Industry
  • 12.6.3. Academic and Research Institutes
  • 12.6.4. Cell Culture/ Biotechnology
  • 12.6.5. Cosmetic Industry
  • 12.6.6. Pharmaceutical Industry
  • 12.6.7. Diagnostics Industry
  • 12.6.8. Others
• 12.7. Market Value Forecast, by Country, 2020-2034
  • 12.7.1. U.S.
  • 12.7.2. Canada
• 12.8. Market Attractiveness Analysis
  • 12.8.1. By Product
  • 12.8.2. By Technology
  • 12.8.3. By Derivative Type
  • 12.8.4. By Source
  • 12.8.5. By End-user
  • 12.8.6. By Country

13. Europe Bovine Blood Plasma Derivatives Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Product, 2020-2034
  • 13.2.1. Kits and Reagents
  • 13.2.2. Instruments
  • 13.2.3. Software and Service
• 13.3. Market Value Forecast, by Technology, 2020-2034
  • 13.3.1. Molecular Diagnostics
  • 13.3.2. Hematology
  • 13.3.3. Immunodiagnostics
  • 13.3.4. Others
• 13.4. Market Value Forecast, by Derivative Type, 2020-2034
  • 13.4.1. Immunoglobulin
  • 13.4.2. Fibrinogen
  • 13.4.3. Serum Albumin
  • 13.4.4. Fetal Bovine Serum
  • 13.4.5. Thrombin
  • 13.4.6. Transferrin
  • 13.4.7. Others
• 13.5. Market Value Forecast, by Source, 2020-2034
  • 13.5.1. US Grade
  • 13.5.2. Australia Grade
  • 13.5.3. New Zealand Grade
  • 13.5.4. Others
• 13.6. Market Value Forecast, by End-user, 2020-2034
  • 13.6.1. Veterinary Industry
    • 13.6.1.1. Veterinary Hospitals
    • 13.6.1.2. Veterinary Reference Laboratories
    • 13.6.1.3. POC/In House Testing
    • 13.6.1.4. Veterinary Research laboratories
  • 13.6.2. Food Industry
  • 13.6.3. Academic and Research Institutes
  • 13.6.4. Cell Culture/ Biotechnology
  • 13.6.5. Cosmetic Industry
  • 13.6.6. Pharmaceutical Industry
  • 13.6.7. Diagnostics Industry
  • 13.6.8. Others
• 13.7. Market Value Forecast, by Country/Sub-region, 2020-2034
  • 13.7.1. Germany
  • 13.7.2. UK
  • 13.7.3. France
  • 13.7.4. Italy
  • 13.7.5. Spain
  • 13.7.6. Rest of Europe
• 13.8. Market Attractiveness Analysis
  • 13.8.1. By Product
  • 13.8.2. By Technology
  • 13.8.3. By Derivative Type
  • 13.8.4. By Source
  • 13.8.5. By End-user
  • 13.8.6. By Country/Sub-region

14. Asia Pacific Bovine Blood Plasma Derivatives Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast, by Product, 2020-2034
  • 14.2.1. Kits and Reagents
  • 14.2.2. Instruments
  • 14.2.3. Software and Service
• 14.3. Market Value Forecast, by Technology, 2020-2034
  • 14.3.1. Molecular Diagnostics
  • 14.3.2. Hematology
  • 14.3.3. Immunodiagnostics
  • 14.3.4. Others
• 14.4. Market Value Forecast, by Derivative Type, 2020-2034
  • 14.4.1. Immunoglobulin
  • 14.4.2. Fibrinogen
  • 14.4.3. Serum Albumin
  • 14.4.4. Fetal Bovine Serum
  • 14.4.5. Thrombin
  • 14.4.6. Transferrin
  • 14.4.7. Others
• 14.5. Market Value Forecast, by Source, 2020-2034
  • 14.5.1. US Grade
  • 14.5.2. Australia Grade
  • 14.5.3. New Zealand Grade
  • 14.5.4. Others
• 14.6. Market Value Forecast, by End-user, 2020-2034
  • 14.6.1. Veterinary Industry
    • 14.6.1.1. Veterinary Hospitals
    • 14.6.1.2. Veterinary Reference Laboratories
    • 14.6.1.3. POC/In House Testing
    • 14.6.1.4. Veterinary Research laboratories
  • 14.6.2. Food Industry
  • 14.6.3. Academic and Research Institutes
  • 14.6.4. Cell Culture/ Biotechnology
  • 14.6.5. Cosmetic Industry
  • 14.6.6. Pharmaceutical Industry
  • 14.6.7. Diagnostics Industry
  • 14.6.8. Others
• 14.7. Market Value Forecast, by Country/Sub-region, 2020-2034
  • 14.7.1. China
  • 14.7.2. Japan
  • 14.7.3. India
  • 14.7.4. Australia & New Zealand
  • 14.7.5. Rest of Asia Pacific
• 14.8. Market Attractiveness Analysis
  • 14.8.1. By Product
  • 14.8.2. By Technology
  • 14.8.3. By Derivative Type
  • 14.8.4. By Source
  • 14.8.5. By End-user
  • 14.8.6. By Country/Sub-region

15. Latin America Bovine Blood Plasma Derivatives Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast, by Product, 2020-2034
  • 15.2.1. Kits and Reagents
  • 15.2.2. Instruments
  • 15.2.3. Software and Service
• 15.3. Market Value Forecast, by Technology, 2020-2034
  • 15.3.1. Molecular Diagnostics
  • 15.3.2. Hematology
  • 15.3.3. Immunodiagnostics
  • 15.3.4. Others
• 15.4. Market Value Forecast, by Derivative Type, 2020-2034
  • 15.4.1. Immunoglobulin
  • 15.4.2. Fibrinogen
  • 15.4.3. Serum Albumin
  • 15.4.4. Fetal Bovine Serum
  • 15.4.5. Thrombin
  • 15.4.6. Transferrin
  • 15.4.7. Others
• 15.5. Market Value Forecast, by Source, 2020-2034
  • 15.5.1. US Grade
  • 15.5.2. Australia Grade
  • 15.5.3. New Zealand Grade
  • 15.5.4. Others
• 15.6. Market Value Forecast, by End-user, 2020-2034
  • 15.6.1. Veterinary Industry
    • 15.6.1.1. Veterinary Hospitals
    • 15.6.1.2. Veterinary Reference Laboratories
    • 15.6.1.3. POC/In House Testing
    • 15.6.1.4. Veterinary Research laboratories
  • 15.6.2. Food Industry
  • 15.6.3. Academic and Research Institutes
  • 15.6.4. Cell Culture/ Biotechnology
  • 15.6.5. Cosmetic Industry
  • 15.6.6. Pharmaceutical Industry
  • 15.6.7. Diagnostics Industry
  • 15.6.8. Others
• 15.7. Market Value Forecast, by Country/Sub-region, 2020-2034
  • 15.7.1. Brazil
  • 15.7.2. Mexico
  • 15.7.3. Rest of Latin America
• 15.8. Market Attractiveness Analysis
  • 15.8.1. By Product
  • 15.8.2. By Technology
  • 15.8.3. By Derivative Type
  • 15.8.4. By Source
  • 15.8.5. By End-user
  • 15.8.6. By Country/Sub-region

16. Middle East & Africa Bovine Blood Plasma Derivatives Market Analysis and Forecast

• 16.1. Introduction
  • 16.1.1. Key Findings
• 16.2. Market Value Forecast, by Product, 2020-2034
  • 16.2.1. Kits and Reagents
  • 16.2.2. Instruments
  • 16.2.3. Software and Service
• 16.3. Market Value Forecast, by Technology, 2020-2034
  • 16.3.1. Molecular Diagnostics
  • 16.3.2. Hematology
  • 16.3.3. Immunodiagnostics
  • 16.3.4. Others
• 16.4. Market Value Forecast, by Derivative Type, 2020-2034
  • 16.4.1. Immunoglobulin
  • 16.4.2. Fibrinogen
  • 16.4.3. Serum Albumin
  • 16.4.4. Fetal Bovine Serum
  • 16.4.5. Thrombin
  • 16.4.6. Transferrin
  • 16.4.7. Others
• 16.5. Market Value Forecast, by Source, 2020-2034
  • 16.5.1. US Grade
  • 16.5.2. Australia Grade
  • 16.5.3. New Zealand Grade
  • 16.5.4. Others
• 16.6. Market Value Forecast, by End-user, 2020-2034
  • 16.6.1. Veterinary Industry
    • 16.6.1.1. Veterinary Hospitals
    • 16.6.1.2. Veterinary Reference Laboratories
    • 16.6.1.3. POC/In House Testing
    • 16.6.1.4. Veterinary Research laboratories
  • 16.6.2. Food Industry
  • 16.6.3. Academic and Research Institutes
  • 16.6.4. Cell Culture/ Biotechnology
  • 16.6.5. Cosmetic Industry
  • 16.6.6. Pharmaceutical Industry
  • 16.6.7. Diagnostics Industry
  • 16.6.8. Others
• 16.7. Market Value Forecast, by Country/Sub-region, 2020-2034
  • 16.7.1. GCC Countries
  • 16.7.2. South Africa
  • 16.7.3. Rest of Middle East & Africa
• 16.8. Market Attractiveness Analysis
  • 16.8.1. By Product
  • 16.8.2. By Technology
  • 16.8.3. By Derivative Type
  • 16.8.4. By Source
  • 16.8.5. By End-user
  • 16.8.6. By Country/Sub-region

17. Competition Landscape

• 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 17.2. Market Share Analysis, by Company (2023)
• 17.3. Company Profiles
  • 17.3.1. ANZCO Foods (Itoham Yonekyu Holdings)
    • 17.3.1.1. Company Overview
    • 17.3.1.2. Financial Overview
    • 17.3.1.3. Product Portfolio
    • 17.3.1.4. Business Strategies
    • 17.3.1.5. Recent Developments
  • 17.3.2. Bovogen Biologicals Pty Ltd. (ANZCO Foods Healthcare)
    • 17.3.2.1. Company Overview
    • 17.3.2.2. Financial Overview
    • 17.3.2.3. Product Portfolio
    • 17.3.2.4. Business Strategies
    • 17.3.2.5. Recent Developments
  • 17.3.3. Moregate Biotech (ANZCO Foods)
    • 17.3.3.1. Company Overview
    • 17.3.3.2. Financial Overview
    • 17.3.3.3. Product Portfolio
    • 17.3.3.4. Business Strategies
    • 17.3.3.5. Recent Developments
  • 17.3.4. Proliant Health & Biologicals
    • 17.3.4.1. Company Overview
    • 17.3.4.2. Financial Overview
    • 17.3.4.3. Product Portfolio
    • 17.3.4.4. Business Strategies
    • 17.3.4.5. Recent Developments
  • 17.3.5. LAMPIRE Biological Laboratories, Inc.
    • 17.3.5.1. Company Overview
    • 17.3.5.2. Financial Overview
    • 17.3.5.3. Product Portfolio
    • 17.3.5.4. Business Strategies
    • 17.3.5.5. Recent Developments
  • 17.3.6. Rocky Mountain Biologicals, LLC
    • 17.3.6.1. Company Overview
    • 17.3.6.2. Financial Overview
    • 17.3.6.3. Product Portfolio
    • 17.3.6.4. Business Strategies
    • 17.3.6.5. Recent Developments
  • 17.3.7. Thermo Fisher Scientific Inc.
    • 17.3.7.1. Company Overview
    • 17.3.7.2. Financial Overview
    • 17.3.7.3. Product Portfolio
    • 17.3.7.4. Business Strategies
    • 17.3.7.5. Recent Developments
  • 17.3.8. Sigma-Aldrich (Merck KGaA)
    • 17.3.8.1. Company Overview
    • 17.3.8.2. Financial Overview
    • 17.3.8.3. Product Portfolio
    • 17.3.8.4. Business Strategies
    • 17.3.8.5. Recent Developments
  • 17.3.9. Kraeber & Co GmbH
    • 17.3.9.1. Company Overview
    • 17.3.9.2. Financial Overview
    • 17.3.9.3. Product Portfolio
    • 17.3.9.4. Business Strategies
    • 17.3.9.5. Recent Developments
  • 17.3.10. Auckland BioSciences
    • 17.3.10.1. Company Overview
    • 17.3.10.2. Financial Overview
    • 17.3.10.3. Product Portfolio
    • 17.3.10.4. Business Strategies
    • 17.3.10.5. Recent Developments
  • 17.3.11. Lake Immunogenics
    • 17.3.11.1. Company Overview
    • 17.3.11.2. Financial Overview
    • 17.3.11.3. Product Portfolio
    • 17.3.11.4. Business Strategies
    • 17.3.11.5. Recent Developments